Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|October 25, 2008
The NF-kappaB inhibitors (bortezomib and DHMEQ) sensitise rituximab-resistant AIDS-B-non-Hodgkin lymphoma to apoptosis by various chemotherapeutic drugsMario I Vega, Melissa Martinez-Paniagua, Ali R Jazirehi, et al.
Materials (Basel, Switzerland)|July 8, 2020
Influence of Controlled Cooling on Crystallinity of Poly (L-Lactic Acid) Scaffolds after Hydrolytic DegradationJavier Vazquez-Armendariz, Raquel Tejeda-Alejandre, Aida Rodriguez-Garcia, et al.
Molecular Cancer Therapeutics|January 24, 2012
Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugsMelisa A Martinez-Paniagua, Mario I Vega, Sara Huerta-Yepez, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|October 13, 2009
[Epidemiological characteristics and risk factors for apparent life-threatening events]J Sánchez Etxaniz, M Santiago Burruchaga, A González Hermosa, et al.
The Journal of Cell Biology|September 6, 2001
A novel fibronectin binding site required for fibronectin fibril growth during matrix assemblyJ L Sechler, H Rao, A M Cumiskey, et al.
Nitric Oxide : Biology and Chemistry|December 19, 2012
Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancerSara Huerta-Yepez, Stavroula Baritaki, Guillermina Baay-Guzman, et al.
International Journal of Oncology|June 15, 2013
Galiximab (anti-CD80)-induced growth inhibition and prolongation of survival in vivo of B-NHL tumor xenografts and potentiation by the combination with fludarabineKandasamy Hariharan, Peter Chu, Tracey Murphy, et al.
International Journal of Oncology|September 24, 2015
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapyGabriel G Vega, Luz Areli Franco-Cea, Sara Huerta-Yepez, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular|July 7, 2023
Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistent prostate cancerM Vidal, R Cárdenas-Perilla, A Delgado, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2011
Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosisMelisa A Martínez-Paniagua, Stavroula Baritaki, Sara Huerta-Yepez, et al.
Pageof 12